Successful Treatment of Sjögren’s Syndrome Presenting as a Condition Similar to Chronic Capillary Leak Syndrome Using Combination Therapy with High-Dose Intravenous Immunoglobulin and Glucocorticoid

Table 1

Laboratory data on first admission.

Peripheral blood		Biochemistry		Immunological test
WBC	7480 mm^3	Total protein	6.1 g/dL	IgG	982 mg/dL
Neutrophil	55%	Albumin	2.9 g/dL	IgA	257 mg/dL
Lymphocyte	29.5%	AST	23 U/L	IgM	241 mg/dL
Monocyte	6.6%	ALT	14 U/L	ANA
Eosinophil	8%	LDH	176 U/L	Centromere pattern	×640
Basophil	0.9%	γ-GTP	42 U/L	Anti-SSA antibody	48.2 U/mL
Red blood cell	508 × 10^4 mm^3	Blood urea nitrogen	9.2 mg/dL	Anti-SSB antibody	<0.5 U/mL
Hb	14.9 g/dL	Creatinine	0.71 mg/dL	Pleural effusion
Hematocrit	45.6%	C-reactive protein	0.11 mg/dL	WBC	470 mm^3
MCV	90 fL	Endocrine		Mononuclear cell	92.2%
Platelet	30.4 × 10^4 mm^3	TSH	2.48 µIU/mL	Polynuclear cell	7.8%
		FT3	3 pg/mL	Total protein	3.6 g/dL
		FT4	1.3 ng/dL	LDH	108 U/L

MCV: mean corpuscular volume; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; γ-GTP: γ-glutamyl transpeptidase; TSH: thyroid-stimulating hormone; FT3: free triiodothyronine; FT4: free thyroxine; ANA: antinuclear antibody.